Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Latham SL, Ehmke N, Reinke PYA, Taft MH, Eicke D, Reindl T, Stenzel W, Lyons MJ, Friez MJ, Lee JA, Hecker R, Frühwald MC, Becker K, Neuhann TM, Horn D, Schrock E, Niehaus I, Sarnow K, Grützmann K, Gawehn L, Klink B, Rump A, Chaponnier C, Figueiredo C, Knöfler R, Manstein DJ, Di Donato N.

Nat Commun. 2018 Nov 19;9(1):4930. doi: 10.1038/s41467-018-07404-6.

2.

Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Latham SL, Ehmke N, Reinke PYA, Taft MH, Eicke D, Reindl T, Stenzel W, Lyons MJ, Friez MJ, Lee JA, Hecker R, Frühwald MC, Becker K, Neuhann TM, Horn D, Schrock E, Niehaus I, Sarnow K, Grützmann K, Gawehn L, Klink B, Rump A, Chaponnier C, Figueiredo C, Knöfler R, Manstein DJ, Di Donato N.

Nat Commun. 2018 Oct 12;9(1):4250. doi: 10.1038/s41467-018-06713-0. Erratum in: Nat Commun. 2018 Nov 19;9(1):4930.

3.
4.

PLK1 phosphorylates PAX3-FOXO1, the inhibition of which triggers regression of alveolar Rhabdomyosarcoma.

Thalhammer V, Lopez-Garcia LA, Herrero-Martin D, Hecker R, Laubscher D, Gierisch ME, Wachtel M, Bode P, Nanni P, Blank B, Koscielniak E, Schäfer BW.

Cancer Res. 2015 Jan 1;75(1):98-110. doi: 10.1158/0008-5472.CAN-14-1246. Epub 2014 Nov 14.

5.

Predicting nurses' well-being from job demands and resources: a cross-sectional study of emotional labour.

Chou HY, Hecker R, Martin A.

J Nurs Manag. 2012 May;20(4):502-11. doi: 10.1111/j.1365-2834.2011.01305.x. Epub 2011 Sep 13.

PMID:
22591152
6.

p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment.

Hecker RM, Amstutz RA, Wachtel M, Walter D, Niggli FK, Schäfer BW.

Oncogene. 2010 Jul 8;29(27):3942-52. doi: 10.1038/onc.2010.145. Epub 2010 May 10.

PMID:
20453878
7.

Protection of chickens against a lethal challenge of Escherichia coli by a vaccine containing CpG oligodeoxynucleotides as an adjuvant.

Gomis S, Babiuk L, Allan B, Willson P, Waters E, Hecker R, Potter A.

Avian Dis. 2007 Mar;51(1):78-83.

PMID:
17461270
8.

The effect of CpG-ODN on antigen presenting cells of the foal.

Flaminio MJ, Borges AS, Nydam DV, Horohov DW, Hecker R, Matychak MB.

J Immune Based Ther Vaccines. 2007 Jan 25;5:1.

9.

Immunostimulatory CpG oligodeoxynucleotides enhance the induction of bovine CD4+ cytotoxic T-lymphocyte responses against the polymorphic immunodominant molecule of the protozoan parasite Theileria parva.

Graham SP, Saya R, Awino E, Ngugi D, Nyanjui JK, Hecker R, Taracha EL, Nene V.

Vet Immunol Immunopathol. 2007 Feb 15;115(3-4):383-9. Epub 2006 Nov 21.

PMID:
17197038
10.

Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.

Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, Townsend HG.

Vet Immunol Immunopathol. 2006 Nov 15;114(1-2):103-10. Epub 2006 Sep 6.

PMID:
16950519
11.

[100 years Albert Hofmann: LSD--miracle drug and problem child, Basel, January 13-15, 2006].

Hecker RM.

Psychiatr Prax. 2006 May;33(4):201-2. German. No abstract available.

PMID:
16680629
12.

Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding.

Nichani AK, Mena A, Kaushik RS, Mutwiri GK, Townsend HG, Hecker R, Krieg AM, Babiuk LA, Griebel PJ.

Oligonucleotides. 2006 Spring;16(1):58-67.

PMID:
16584295
13.

Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs.

Alcon V, Baca-Estrada M, Vega-Lopez M, Willson P, Babiuk LA, Kumar P, Hecker R, Foldvari M.

AAPS J. 2005 Oct 14;7(3):E566-71.

14.

Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration.

Babiuk S, Baca-Estrada ME, Middleton DM, Hecker R, Babiuk LA, Foldvari M.

Curr Drug Deliv. 2004 Jan;1(1):9-15.

PMID:
16305366
15.

Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.

Griebel PJ, Brownlie R, Manuja A, Nichani A, Mookherjee N, Popowych Y, Mutwiri G, Hecker R, Babiuk LA.

Vet Immunol Immunopathol. 2005 Oct 18;108(1-2):11-6. Review.

PMID:
16098606
16.

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.

Wedlock DN, Skinner MA, de Lisle GW, Vordermeier HM, Hewinson RG, Hecker R, van Drunen Littel-van den Hurk S, Babiuk LA, Buddle BM.

Vet Immunol Immunopathol. 2005 Jun 15;106(1-2):53-63.

PMID:
15910992
17.

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

Rummel MJ, Al-Batran SE, Kim SZ, Welslau M, Hecker R, Kofahl-Krause D, Josten KM, Dürk H, Rost A, Neise M, von Grünhagen U, Chow KU, Hansmann ML, Hoelzer D, Mitrou PS.

J Clin Oncol. 2005 May 20;23(15):3383-9.

PMID:
15908650
18.

Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

Wedlock DN, Denis M, Skinner MA, Koach J, de Lisle GW, Vordermeier HM, Hewinson RG, van Drunen Littel-van den Hurk S, Babiuk LA, Hecker R, Buddle BM.

Infect Immun. 2005 Jun;73(6):3540-6.

19.

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c.

Vordermeier HM, Pontarollo R, Karvonen B, Cockle P, Hecker R, Singh M, Babiuk LA, Hewinson RG, van Drunen Littel-van Den Hurk S.

Vaccine. 2005 Aug 15;23(35):4375-84.

PMID:
15908057
20.

Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs.

Gomis S, Babiuk L, Allan B, Willson P, Waters E, Ambrose N, Hecker R, Potter A.

Avian Dis. 2004 Dec;48(4):813-22.

PMID:
15666862
21.

TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

Babiuk S, Mookherjee N, Pontarollo R, Griebel P, van Drunen Littel-van den Hurk S, Hecker R, Babiuk L.

Immunology. 2004 Sep;113(1):114-20.

22.

CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii.

Kringel H, Dubey JP, Beshah E, Hecker R, Urban JF Jr.

Vet Parasitol. 2004 Aug 13;123(1-2):55-66.

PMID:
15265571
23.

In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep.

Nichani AK, Mena A, Popowych Y, Dent D, Townsend HG, Mutwiri GK, Hecker R, Babiuk LA, Griebel PJ.

Vet Immunol Immunopathol. 2004 Mar;98(1-2):17-29.

PMID:
15127838
24.

CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep.

Nichani AK, Kaushik RS, Mena A, Popowych Y, Dent D, Townsend HG, Mutwiri G, Hecker R, Babiuk LA, Griebel PJ.

Cell Immunol. 2004 Jan;227(1):24-37.

PMID:
15051512
25.

An holistic economic evaluation of an Aboriginal community-controlled midwifery programme in Western Sydney.

Jan S, Conaty S, Hecker R, Bartlett M, Delaney S, Capon T.

J Health Serv Res Policy. 2004 Jan;9(1):14-21.

PMID:
15006235
26.

Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide.

Mena A, Nichani AK, Popowych Y, Ioannou XP, Godson DL, Mutwiri GK, Hecker R, Babiuk LA, Griebel P.

Oligonucleotides. 2003;13(4):245-59.

PMID:
15000839
27.

The phenotype of the Arabidopsis cue1 mutant is not simply caused by a general restriction of the shikimate pathway.

Voll L, Häusler RE, Hecker R, Weber A, Weissenböck G, Fiene G, Waffenschmidt S, Flügge UI.

Plant J. 2003 Nov;36(3):301-17.

28.

Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells.

Mena A, Nichani AK, Popowych Y, Godson DL, Dent D, Townsend HG, Mutwiri GK, Hecker R, Babiuk LA, Griebel P.

Immunology. 2003 Oct;110(2):250-7.

29.

Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits.

Ioannou XP, Gomis SM, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2003 Oct 1;21(27-30):4368-72.

PMID:
14505919
30.

Safety of CpG oligodeoxynucleotides in veterinary species.

Ioannou XP, Griebel P, Mena A, Gomis SM, Godson DL, Mutwiri G, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

Antisense Nucleic Acid Drug Dev. 2003;13(3):157-67.

PMID:
12954116
31.

Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family.

Lindner HA, Lunin VV, Alary A, Hecker R, Cygler M, Ménard R.

J Biol Chem. 2003 Nov 7;278(45):44496-504. Epub 2003 Aug 21.

32.

Molecular approaches to disease control.

Babiuk LA, Gomis S, Hecker R.

Poult Sci. 2003 Jun;82(6):870-5. Review.

PMID:
12817439
33.

Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix).

Alcón VL, Foldvari M, Snider M, Willson P, Gomis S, Hecker R, Babiuk LA, Baca-Estrada ME.

Vaccine. 2003 May 16;21(17-18):1811-4.

PMID:
12706664
34.

Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs.

Hogarth PJ, Jahans KJ, Hecker R, Hewinson RG, Chambers MA.

Vaccine. 2003 Feb 14;21(9-10):977-82.

PMID:
12547611
35.

Biological activity of immunostimulatory CpG DNA motifs in domestic animals.

Mutwiri G, Pontarollo R, Babiuk S, Griebel P, van Drunen Littel-van den Hurk S, Mena A, Tsang C, Alcon V, Nichani A, Ioannou X, Gomis S, Townsend H, Hecker R, Potter A, Babiuk LA.

Vet Immunol Immunopathol. 2003 Jan 30;91(2):89-103. Review.

PMID:
12543546
36.

Protection of chickens against Escherichia coli infections by DNA containing CpG motifs.

Gomis S, Babiuk L, Godson DL, Allan B, Thrush T, Townsend H, Willson P, Waters E, Hecker R, Potter A.

Infect Immun. 2003 Feb;71(2):857-63.

37.

Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors.

Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S.

J Gen Virol. 2002 Dec;83(Pt 12):2973-81.

PMID:
12466473
38.

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

Ioannou XP, Gomis SM, Karvonen B, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2002 Nov 22;21(1-2):127-37.

PMID:
12443671
39.

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.

Ioannou XP, Griebel P, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

J Virol. 2002 Sep;76(18):9002-10.

40.

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D.

Rankin R, Pontarollo R, Gomis S, Karvonen B, Willson P, Loehr BI, Godson DL, Babiuk LA, Hecker R, van Drunen Littel-van den Hurk S.

Vaccine. 2002 Jul 26;20(23-24):3014-22.

PMID:
12126915
41.

Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs.

Pontarollo RA, Rankin R, Babiuk LA, Godson DL, Griebel PJ, Hecker R, Krieg AM, van Drunen Littel-van den Hurk S.

Vet Immunol Immunopathol. 2002 Jan 1;84(1-2):43-59.

PMID:
11825597
42.

CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation.

Wernette CM, Smith BF, Barksdale ZL, Hecker R, Baker HJ.

Vet Immunol Immunopathol. 2002 Jan 15;84(3-4):223-36.

PMID:
11777536
43.

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved.

Rankin R, Pontarollo R, Ioannou X, Krieg AM, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40.

PMID:
11763350
44.

Editorial. Turning potential into realities.

Gölitz P, Hecker R.

Chemphyschem. 2001 Sep 17;2(8-9):473-4. doi: 10.1002/1439-7641(20010917)2:8/9<473::AID-CPHC473>3.0.CO;2-Y. No abstract available.

PMID:
23686983
45.

Role of nitric oxide synthase in the light-induced development of sporangiophores in Phycomyces blakesleeanus.

Maier J, Hecker R, Rockel P, Ninnemann H.

Plant Physiol. 2001 Jul;126(3):1323-30.

46.

Response to nitrogen starvation in Corynebacterium glutamicum.

Schmi R, Uhlemann EM, Nolden L, Wersch G, Hecker R, Hermann T, Marx A, Burkovski A.

FEMS Microbiol Lett. 2000 Jun 1;187(1):83-8.

47.
48.

Participatory action research as a strategy for empowering aboriginal health workers.

Hecker R.

Aust N Z J Public Health. 1997 Dec;21(7):784-8.

PMID:
9489200
49.

Myocardial ischemia and stunning induced by topical intranasal phenylephrine pledgets.

Hecker RB, Hays JV, Champ JD, Rubal BJ.

Mil Med. 1997 Dec;162(12):832-5.

PMID:
9433094
50.

Dissociation of visual and spatial processing in working memory.

Hecker R, Mapperson B.

Neuropsychologia. 1997 May;35(5):599-603.

PMID:
9153022

Supplemental Content

Loading ...
Support Center